Stibbe advises leading plasma protein biotherapeutics company

BE Law

Stibbe advised one of the world's leading plasma protein biotherapeutics companies in relation to Belgium's implementation of a new Act concerning public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.

This matter was very important to our client considering that the new legislation might have significant impact on its hospital market share.